Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma C Pérez, J González-Rincón, A Onaindia, C Almaráz, N García-Díaz, ... Haematologica 100 (11), e450, 2015 | 78 | 2015 |
Advanced‐stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor‐κB and nuclear factor of activated T cells pathways C Pérez, R Mondéjar, N García‐Díaz, L Cereceda, A León, S Montes, ... British Journal of Dermatology 182 (1), 147-155, 2020 | 54 | 2020 |
Mycosis fungoides and sézary syndrome: An integrative review of the pathophysiology, molecular drivers, and targeted therapy N García-Díaz, MÁ Piris, PL Ortiz-Romero, JP Vaqué Cancers 13 (8), 1931, 2021 | 43 | 2021 |
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics F Ruso-Julve, A Pombero, F Pilar-Cuéllar, N García-Díaz, R Garcia-Lopez, ... Translational Psychiatry 9 (1), 306, 2019 | 23 | 2019 |
Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma R Alonso-Alonso, R Mondéjar, N Martínez, N García-Diaz, C Pérez, ... Scientific reports 10 (1), 6721, 2020 | 10 | 2020 |
Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR S Llerena, N García-Díaz, S Curiel-Olmo, A Agraz-Doblas, ... Oncotarget 9 (56), 30869, 2018 | 10 | 2018 |
PLCγ1/PKCθ downstream signaling controls cutaneous T-cell lymphoma development and progression N García-Díaz, B Casar, R Alonso-Alonso, L Quevedo, M Rodríguez, ... Journal of Investigative Dermatology 142 (5), 1391-1400. e15, 2022 | 7 | 2022 |
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures S Curiel-Olmo, A García-Castaño, R Vidal, H Pisonero, I Varela, ... Oncotarget 6 (28), 25452, 2015 | 5 | 2015 |
Erratum: Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures S Curiel-Olmo, A García-Castaño, R Vidal, H Pisonero, I Varela, ... Oncotarget 7 (5), 6352, 2016 | | 2016 |